A mouse protozoan boosts antigen-specific mucosal IgA responses in a specific lipid metabolism- and signaling-dependent manner-Reference-Cited by-同舟云学术

A mouse protozoan boosts antigen-specific mucosal IgA responses in a specific lipid metabolism- and signaling-dependent manner

Published:2024-09-10 Issue:1 Volume:15 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Kou Yanbo^ORCID,Zhang Shenghan,Chen Junru,Shen Yusi,Zhang Zhiwei,Huang Haohan,Ma Yulu,Xiang Yaoyao,Liao Longxiang,Zhou Junyang,Cheng Wanpeng,Zhou Yuan,Yang Huan,Liu Zhuanzhuan,Wei Yanxia,Wang Hui,Wang Yugang^ORCID

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Special Funds of Xuzhou for Promoting Scientific and Technological Innovation

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41467-024-52336-z.pdf

Reference66 articles.

1. Sterlin, D. et al. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Sci. Transl. Med. 13, eabd2223 (2021).

2. Wang, Z. et al. Enhanced SARS-CoV-2 neutralization by dimeric IgA. Sci. Transl. Med. 13, eabf1555 (2021).

3. Liew, F. Y., Russell, S. M., Appleyard, G., Brand, C. M. & Beale, J. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur. J. Immunol. 14, 350–356 (1984).

4. Asahi-Ozaki, Y. et al. Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus. J. Med. Virol. 74, 328–335 (2004).

5. Okuya, K. et al. Potential role of nonneutralizing IgA antibodies in cross-protective immunity against influenza A viruses of multiple hemagglutinin subtypes. J. Virol. 94, e00408–20 (2020).